4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0000947871-18-000492
Director sold 18,700 shares at an average $13.56 ($253,631)
From the SEC's structured data for this filing
Trades in this filing
ORBIMED ADVISORS LLC · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-04 | Sale : show line 1 in the form | −17,100 | $13.57 | $232,047 | 4,902,910 | I |
| 2018-06-06 | Sale : show line 2 in the form | −1,600 | $13.49 | $21,584 | 4,901,310 | I |
| Open-market sales · 18,700 sh · avg $13.56 · $253,631 | ||||||
Loading xslF345X03/ss95078_4.xml…